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ABSTRACT 
Objectives: This study investigated the benefits of, and barriers to user involvement 
in medical device technology development and evaluation. Methods: A structured 
review of published literature in peer-reviewed journals. Results: This review 
revealed that the main benefits of user involvement were an increased access to user 
needs, experiences and ideas; improvements in medical device designs and user 
interfaces; and an increase in the functionality, usability and quality of the devices. On 
the other hand, resource issues, particularly those of time and money were found the 
key impediments to involving users in the development and evaluation of medical 
device technologies. This study has categorised both the benefits and barriers to user 
involvement also. Conclusions: The involvement of users in MDTD&E requires 
resources, which are limited; however, it is essential from both users and 
manufacturers perspectives. 
 
Keywords: User, Medical devices, User involvement, Benefits and barriers, 
Development and evaluation, Assistive devices, Healthcare technology 
INTRODUCTION 
Users of medical devices are involved in the development and evaluation of medical 
device technology due to their potentially vital role in the innovation, development, 
assessment, implementation and dissemination of the technology (1;3). Engagement 
with the users is also now required under medical device regulations (66). However, 
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such  engagement is also associated with benefits and costs (20) that may encourage 
or discourage involvement of users in the development and evaluation of a particular 
technology. Therefore, this paper attempts to investigate the benefits of and barriers to 
the involvement of users in medical device technology development and evaluation 
(MDTD&E) and to identify the policy implications.  
METHODS 
This paper is based on a review of carefully selected social science literature i.e. 
twenty-five studies that reported involvement of users in the development and 
evaluation of medical device technologies. The studies were identified through a 
rigorous and structured review of studies of user involvement in the medical device 
technology lifecycle published in peer-reviewed journals from 1980 to 2005, but in 
the English language.  
 The online bibliographic databases searched were Blackwell synergy, 
EBSCOhost, Emerald, International Bibliography of the Social Sciences, 
Inderscience, InfoTrac, Ingenta, JSTOR, Medical device link, ProQuest, Sage, 
ScienceDirect, Social Science Information Gateway (Sosig), SpringerLink and Taylor 
& Francis.  
 The studies were reviewed twice. During the first review, which took place 
from January 2004 to May 2005, information regarding types of methods, medical 
devices, the possible involvement of users, and the stages of the technology 
development cycle used, was extracted, which is reported elsewhere (71). The second 
review was conducted between September 2005 and February 2006 specifically to 
investigate the benefits of and barriers to the involvement of users in MDTD&E. The 
justification for re-reviewing the studies with this emphasis was that the earlier review 
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neither investigated nor reported the reasons for involvement or non-involvement of 
users in the medical device lifecycle. 
 The precise objectives of the second review were to find out answers to the 
following questions. Why were the users involved in MDTD&E? What were the 
factors that either encouraged or discouraged the involvement of users in MDTD&E? 
What are the policy implications of involving users in MDTD&E? 
 In this paper, medical device technologies are taken to include all medical 
devices and assistive technology devices as defined by the Global Harmonization 
Task Force (81) and the US legislation (27) respectively. 
RESULTS AND DISCUSSION 
This literature review found that user involvement in MDD&E was reported in several 
studies (2;4;6;8;9;13;22-24;31-33;35;36;38;48-50;55;57;61;70;73;74;80). However, 
the number of the studies reporting involvement of users in MDTD&E, the main 
criterion for inclusion, was low. This may be because of confidentiality issues, 
especially in relation to commercially sensitive developments, or more probably 
because of the limited and non-standardised practice of the user involvement in 
MDTD&E over recent years.  
 Detailed analysis in this review reveals some of the key issues in relation to 
the benefits of and barriers to user involvement in MDTD&E presented in tables 1 
and 2 respectively, and discussed in the following sections. 
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Benefits of User Involvement 
This literature review has shown that the major benefits of user involvement in 
MDTD&E include beneficial access to user ideas and perspectives, and improvement 
in the design, user interface, functionality, usability and quality of medical devices. 
 
 Beneficial Access to User Perspectives. The development and evaluation of 
medical device technologies from users’ perspectives, almost by definition,  requires 
the involvement of users themselves (22) because users generate ideas for both new 
(11) and innovative (65;68;79) products; they indicate conceptual deficiencies and 
potential problems in current and future products; and suggest appropriate changes 
and solutions to the problems which those products are seen to pose (28;64;75). In 
addition, engagement with users helps in the elicitation of targeted user needs, 
opinions, expectations and experiences which may well be critical to both the short 
and long term deployment of the product (22;51). In particular the involvement of 
users is  important at each stage of the product development cycle (8) to capitalise in a 
cumulative way on their contributions and thus to maximise their effect. However, it 
is more meaningful and crucial for the nature and direction  of the product if users are 
involved in the early stages, such as  concept and idea generation , as well as design 
(re)development , and prototype testing and trials stage, rather  than only or mainly in 
the late stages of the product lifecycle (67).  
 
 Lead-Users’ Contributions. Amongst the user communities of any 
technology, the lead users, as defined by von Hippel (77), contribute significantly to 
the technology development and evaluation process (34;47;63;76;77). ‘Lead users’ 
provide information about major users’ needs vis-à-vis new products as well as  
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recommending solutions to those needs at an early stage (76). In addition they can 
generate and make explicit key issues regarding  the conceptualisation of new 
products,  and product innovation (56) in less  time and at less cost than the traditional 
ways in which this is usually accomplished (34). Of special value they also suggest 
improvements in user interfaces (22); propose solutions to product problems (17) and 
contribute to the  early adoption (56) and early diffusion of products (76). There is 
also evidence that the identification of lead users’ needs results in the development of 
‘breakthrough’ new products, for example surgical drapes (78), surgical hygiene 
products (52), radically new X-ray systems and new biocompatible implants (45). 
Additionally, the literature shows that  lead users’ ideas are associated with highest 
value of  intellectual property compared to the ideas generated by ‘ordinary’ – later - 
users (47). 
“Take in Table 1” 
 
 User and Producer Interaction. The development of technologies that fulfil 
user needs and expectations requires, in practice, in depth information about the users 
of technologies (7), which among other things requires engagement and 
communication with them. Although this may appear an extremely self-evident point, 
it has often been the case that such data has been extrapolated from general principles 
rather than researched, as it should be, empirically in each case. Communication and 
collaboration between users and manufacturers  needs to be direct particularly in the 
case of improvement of existing devices and development or innovation of complex 
and specialised equipment (30;62), where general extrapolations to ‘user needs’ are of 
limited value. The evidence also shows that the direct and active interaction and 
cooperation between users and producers enhances quality (10;41), functionality, 
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usability, design (43), as well as effectiveness (44), and the adoption of medical 
device technologies (69). For example, improvements in key aspects of a  ventilator 
(24) and the development of a innovative but complex medical device such as a 
neuromagnetometer (32;33;55) showed how the involvement of users was critical. 
 
 Operational and Strategic Gains. This review has found that the involvement 
of users in the product development process helpfully reduces subsequent 
development costs (42;67;68) and just as important time over run (67); it determines 
product success and failure in many cases (25;26;29;46;72) and generally increases 
the value of new products (68). In addition, users play an important role in the 
implementation of new medical device technologies, and their integration in existing 
structures, such as the involvement of clinicians and medical laboratory staff in the 
implementation and integration of patient based record systems in relation to  the wide 
range of tests carried out in microbiology and pathology laboratories (54). 
 
 Regulatory Controls. Another advantage of involving users in MDTD&E is 
the fulfilment of regulatory requirements, which require user participation and user 
focused development of medical device technologies (14;66). This is not just in terms 
of a ritual fulfilment of basic statutory requirements, but in practice in ensuring a 
more effective set of ways in which those requirements can be innovatively met.  
 Thus, involvement of users in MDTD&E is rewarding (8). It helps in 
embedding user perspectives in medical device technologies to the benefit of users 
(51) as well as bringing benefits to the manufacturer through the development of 
successful products, thereby attract higher sales and profits (39;40;59). On the 
contrary, non-involvement of users in MDTD&E may lead to the development of user 
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interfaces that may have significant problems. For example usability problems may 
arise that may lead  to safety issues such as occurrence of errors which would 
otherwise be corrected (22;24), but, without this mechanism of control, that can create 
unwanted and expensive consequences. In addition, there is a likelihood that such 
devices might be rejected by their users since they fail to meet their needs and skills, 
which in the worst case will lead to the financial lack of viability of the product (21).  
Barriers to User Involvement 
This literature review has revealed that the key barriers to user involvement in 
MDTD&E are the demands thus generated for extra resources, mainly in terms of 
time and money involved and their relationship to the user characteristics, availability, 
cooperation, preparation and motivation, in the context of any given product. 
 
 Resources. The most important requirement for involving users in MTD&E is 
the availability of  resources i.e. time, money and labour, which are the most critical 
factors for manufacturers (5;10;24). There is of course no guarantee that the out-come 
of any user involvement will be  positive (5;10;18). Findings from this literature 
review show that it is quite possible that  user involvement in any  product 
development cycle is cost effective (42); however, this involvement  is also very time 
consuming (37;42) and the possibility of time over runs thus implied can not be 
afforded by every manufacturer on every occasion. Therefore, resources are one of the 
major constraints to user involvement in MDTD&E. However, it must be stressed that 
user involvement is, from this study, almost always of great value in creating a 
valuable and marketable product, and thus time over runs have to be set against the 
broader value of the process. It may also be the case that in more regularly 
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incorporating the direct assessment of user needs into the process of product 
development, a more economical and less problematic process will result. 
 
 User Characteristics. This literature review has identified that  users’ 
availability (15;16;53), preparation, training and support (22), cooperation (41;60) and 
characteristics (8;16) are also critical factors in involving them effectively  in the 
product development and evaluation process. For example, involvement of some 
types of users of medical device technologies such as the elderly and persons with 
certain types of disabilities (53) as well as  some categories of clinicians could be 
difficult (15;16) because of their non-availability owing to their personal or 
professional circumstances. In such cases, it is worth considering, even as only a 
temporary expedient, the best possible, and available, surrogates of the particular 
medical device users, in the process of MDTD&E. For example it is possible to 
involve others as representatives (surrogates) instead of less available  physicians 
working in emergency departments in the development and evaluation of patient 
healthcare information systems (15;16). Some of the users of medical device 
technologies such as persons with disabilities, the elderly, and other kinds of patients 
may require additional encouragement and assistance to take part in MDTD&E. 
Furthermore, the extent of user involvement in MDTD&E also depends on the type of 
the medical device technology concerned (8). 
 
 Strategic Considerations. This review has found that it is not possible for 
some potential  users to contribute adequately in development and evaluation of 
specific medical device technologies particularly the more complex technologies (57) 
because they might not possess sufficient technological knowledge and understanding 
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about  products based on such technologies (46). This point should act as a warning to 
manufacturers that they should not expect solutions to complex technical problems 
from such users, concerning medical device technologies, particularly those of a novel 
nature.  However, engagement with such users may be useful for the purpose of 
identification and clarification of user requirements and experiences, as well as in 
relation to  vital features of the products (46). However , despite the general value of 
user involvement, it was found that such involvement does not provide any certainty  
that the products or technologies so developed will be always successful (5;10), or be 
perfect and function smoothly (18). This might be a deterrent for some of 
manufacturers to engage with users for the purpose of MDTD&E, although it must be 
noted that the certainty of success is not warranted by most other factors in the device 
development process. 
“Take in Table 2” 
 
 User-Producer Interaction. Overall the review has found unsurprisingly that  
cooperation between users and producers is essential for successful elicitation of user 
needs and knowledge (60). However, the interaction between users and producers in 
the manufacturing sector including medical device manufacturing processes may not 
be always as expected (12). Thus, the particular nature of the relationship between 
users and manufacturers can be an impediment on occasion to the type and 
effectiveness of user involvement in MDTD&E.  
 
 Manufacturer’s Attitudes. The involvement of users in the technology 
development and evaluation process depends not only on users themselves but also on 
the manufacturer’s willingness to listen to them and integrate their input into the 
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technology development cycle. Therefore, the culture within the manufacturing 
organisation particularly the attitudes of product development personnel may affect 
the involvement of users in MDTD&E because they may regard the idea of user 
involvement overall as less valuable and unnecessary (37); thus, they may therefore 
oppose it (63). In this case, medical device technology manufacturers can be argued to 
need a  cultural shift in attitudes (37) so that there is encouragement of user 
participation in  the technology development and evaluation process (58). On the 
other hand, whilst it is  possible that manufacturers are more than willing to employ 
user input into MDTD&E; however, the processes required for incorporating such 
user perspectives within in the technology development cycle are limited or 
ineffective (19). For example, methodologies that are reliable, robust, fast and cheap 
need to be identified developed and/or modified in order to facilitate the user 
involvement. 
 
 Regulatory Controls. Other factors that can limit involvement of users in 
MDTD&E may include stringent regulatory controls and ethical approvals concerning 
the involvement of users. These may inhibit or prevent the easy incorporation of users 
in various stages of device development. 
LIMITATIONS AND FUTURE RESEARCH 
Limitations  
The findings of this literature review are indicative rather than comprehensive since it 
is mainly based on social sciences literature. The inclusion of broader literature in the 
engineering and medical fields might have been useful, although the authors have 
found that there is generally limited published data in these fields on the issues they 
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have raised here. Another limitation of the literature, which echoes findings in other 
areas, is that that there is a general non-availability of the literature that reports about 
unsuccessful user involvement in MDTD&E. 
Future Research 
Future research could with profit explore methodologies that reduce costs and time 
associated with user involvement in medical device technology development and 
evaluation. 
CONCLUSIONS 
This literature review has revealed that the involvement of users in the development 
and assessment of medical device technologies is associated with significant benefits 
such as the generation of ideas by users, an improvement in device designs and user 
interfaces, much improvement in the functionality, usability and quality of medical 
devices, as well as access to and knowledge about user perspectives vis-à-vis medical 
device technologies. This review has also shown that the key barriers in involving 
users in MDTD&E are non-availability of key users, for various reasons, and the time 
and costs involved in the user involvement.  
 Involvement of users in MDTD&E therefore whilst requiring time, money and 
energy of both users and manufacturers, nevertheless brings benefits for both of these 
two major stakeholders of medical device technologies. Through involvement, users 
can get medical device technologies that fulfil their needs and expectations, which are 
likely to increase demand for such devices, whilst on the other hand manufacturers 
can receive financial gains owing to higher sales of the devices. 
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POLICY IMPLICATIONS 
In recent years, the role of users in the development of any product has been seen as 
of vital significance for the long-term viability of products and their subsequent 
development, it has been recognised that a key role is that of the consumer. However, 
the involvement of users in MDTD&E is either limited or underreported in the 
published literature. This underreporting could be due to either commercial 
confidentiality or a failure to get desired outcomes, or indeed a failure to recognise the 
importance of users as a whole. In addition, the limited practice of involving users 
could be due to financial and time constraints, which manufacturers face, as well as a 
tradition of discretionary involvement of users in the MDTD&E process. This in 
general could be due to the variable recognition and subsequently poor 
institutionalisation of user involvement. Therefore, user involvement needs proper 
integration in the development of medical device technology as the consumer role in 
many aspects of manufacturing and production has become decidedly more robust. It 
would be unwise to allow the more haphazard status of such involvement to continue 
in the form that it has been undertaken in the past. This may however need 
formalisation through the integration of user involvement in the health technology 
assessment (HTA) process requiring approval from both regulators and 
manufacturers.  
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Table 1. Benefits of user involvement in medical device technology development and evaluation 
Category     Benefits References
Strategic  Source of idea generation for new products, product innovation and high 
intellectual property potential 
(33;35) 
Operational  Reduction in development costs e.g. costs incurred on redesigns (8) 
Improvement of user interface  (22;49) 
Identification of conceptual deficiencies and potential problems and 
suggestion of appropriate changes  
(4;8;48;61) 
Improvement in the functionality, effectiveness, usability and design  (9;22;23;36;49;50;57) 
Product 
 
Improvement in the quality and execution (24) 
User  Access to user perspectives e.g. user needs, knowledge, expectations, 
problems, experiences, perceptions, attitudes, satisfaction, rejection and 
acceptance vis-à-vis medical device technologies 
(2;6;13;22;36;38;55;57;70;74;80)
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Table 2. Barriers to user involvement in medical device technology development and evaluation 
 
 
Category    Barriers References
Operational Resources particularly the time and money  (8;24) 
User  Characteristics of users (8) 
 User support, preparation and training (22) 
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